Skip to main content
OpenTrials

Clinical trial condition

Imprinting Disorders

Explore clinical trials studying Imprinting Disorders. Study availability and eligibility vary by location and protocol.

143 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Imprinting Disorders trial results

Active, not recruiting

Long-term Extension of GTX-102 in Angelman Syndrome

NCT06415344

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +7 more
Locations
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
  • University of California, San Diego - Rady Children's Hospital San Diego, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 23 locations
View Trial Details
Active, not recruiting

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

NCT07157254

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +7 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Clinical Trial Site Kansas City, Missouri, United States
  • Rare Disease Research Hillsborough, North Carolina, United States
View all 21 locations
View Trial Details
Active, not recruiting

HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome

NCT05127226

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +7 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Colorado Children's Hospital Research Institute Aurora, Colorado, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)

NCT06617429

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +7 more
Locations
  • Cedars Sinai Los Angeles, California, United States
  • UCSD, Rady Children's Hospital San Diego, California, United States
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS

NCT06144645

Conditions
Abnormalities, Multiple, Chromosome Disorders, Congenital Abnormalities, +13 more
Locations
  • Stanford University Palo Alto, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details

Related conditions